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Abstract 
Zinc and Copper are essential for the immune system and the interaction between reproductive system and 
immune cells plays important immunoregulatory roles in menstrual cycle of women. It is estimated that nearly 
16 million women are living with HIV/AIDS worldwide, making up approximately half of all infections. 
Importantly, the understanding of the burden of HIV/AIDS lies within resource limited areas particularly Sub-
Saharan Africa. This was a prospective study designed to evaluate the immunological implication of Zinc and 
Copper in menstrual cycle of HIV infected females in NAUTH, Nnewi, Nigeria. The study composed of 120 
premenopausal females with regular menstrual cycle (between 27-31 days) and aged 15-45 years. 30 were 
apparently healthy females recruited as Control group while 90 were HIV infected females grouped as HIV stage 
1, HIV stage 2 and HIV stage 2 on ART (n=30 respectively). Blood samples were collected at follicular (7
th 
- 
13
th
 day) and luteal (21
st
 -23
rd
 day) phases of menstrual cycle after obtaining their informed consent for 
determination of Zinc, Copper, Interleukin-6, interleukin-4 and TNFα using AAS and ELISA methods. The 
result showed significantly lower levels of Zn and Cu  with significantly higher levels of IL-6, IL-4 and TNFα in 
HIV infected females with or without therapy compared to Control at both phases of menstrual cycle (P<0.05). 
The Zn levels was significantly higher in stage 2 HIV infected females on ART compared to their counterparts 
not on ART (P<0.05). The significantly lower levels of Zn and Cu with increased levels of cytokines indicate 
immunosuppression and active inflammatory response in HIV infected females at both phases of menstrual cycle 
which was improved in the participants who were placed on ART.   
Keywords: Copper; Zinc; Immunological Implication; HIV; Menstrual cycle; Reproductive age.  
 
1. Introduction 
The interaction between reproductive system and immune cells plays an important immunoregulatory role in 
menstrual cycle of women. Zinc and Copper have been identified as being essential for proper function of the 
reproductive system (Bedwal and Bahuguna, 1994) and immune response (Dunlap et al, 1974, Prasad, 2007). 
Zinc has been associated with proper formation and maturation of T-cells and cellular response to mitogens 
among other immune activities (Klaus-Helge and Lothar, 2003) and Zinc deficiency has been implicated in 
amenorrhea, infertility and premenstrual syndrome (irritability, ache and cramping during menstruation (Canaan, 
2011, Wilson, 2012) and women with eating disorders may be involved and this may affect immunity. Zinc 
deficiency has also been associated with high incidence of infections in the elderly (Prasad, 2007) and this was 
associated with increased productions of inflammatory cytokines and plasma oxidative stress markers. Thus, 
Zinc acts as an anti-inflammatory agent. On the other hand, Zinc supplementation was associated with lower 
incidence of infections, Lower generation of tumour necrosis factor alpha and oxidative stress markers. Zinc is 
very important in HIV-1 infection. This is because Zinc has been found to be a component of HIV-1 
nucleocapsid proteins (Berthoux et al, 1997) and has also a strong affinity for binding with HIV-1 trans-
activating protein (Tat) (Huang and Wang, 1996). The HIV-1 virus also utilizes Zinc for gene expression, 
multimerization and integration hence HIV-1 is said to be a Zinc dependent virus. This may partially explain the 
low levels of Zinc observed in HIV-1 infected patients. Zinc in large dosages, induces the production of 
cytokines such as interleukins IL-1, IL-6 and TNFα and soluble IL-2R (Mocchegiani, 1985). 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol 31, 2015 
 
10 
Copper on the other hand, has been found to be essential for neutrophil mobilization in peripheral 
blood and T-cell proliferation (Percival, 1998). Copper deficiency is associated with neutrophil reduction in 
number, reduced ability to form superoxide anion and ingestion of microorganisms. However, the mechanism of 
action of copper is not yet understood. Studies have shown that copper deficiency reduces the effectiveness of 
the acquired immune response (Lukasewyez and Prohaska, 1990) and neutropenia has been demonstrated in 
humans (Williams, 1983). Copper deficiency has also been associated with arrested maturation of granulocytes 
and impaired phagocytic function (Heresi, 1985).  
The present study was therefore designed to evaluate the immunological implication of zinc and 
copper in menstrual cycle of HIV infected females. 
 
2. Materials and Methods 
2.1 subjects 
A total of 120 premenopausal females with regular menstrual cycle (between 27-31 days) and aged 15-45years 
were randomly recruited for the study. The participants consisted of 30 apparently healthy females recruited 
among the hospital staff who served as Control females while the remaining 90 female participants were 
recruited at Heart to Heart centre and HIV clinic of Nnamdi Azikiwe University Teaching Hospital Nnewi, 
Anambra State Nigeria. They were grouped according to WHO criteria for staging HIV infections as: (i) Stage 1 
HIV infected females (n=30), (ii) Stage 2 HIV infected females (n=30), (iii) Stage 2 HIV infected females on 
ART (n=30). A structured questionnaire was administered to each of these participants to ascertain their 
menstrual cycle and reproductive history and other biodata. 
Six mls of Blood sample was collected from each participant at follicular (7-13
th
 day) and at luteal (21-
23rd day) phases of menstrual cycle. The blood samples were collected between 8 to 10am by venepuncture and 
were dispensed into EDTA containers and were used immediately for malaria parasite screening, HIV screening 
and confirmation. The blood was centrifuged and the plasma content was separated immediately and transferred 
into the well labeled container and stored frozen at -20
0
C until assayed for Zinc, copper, IL-6, IL-4 and TNFα.  
The ethics committee of Nnamdi Azikiwe University Teaching Hospital Nnewi, Anambra state, 
Nigeria approved the study design. The participants were informed about the study design and only those who 
gave their consent were recruited for the study.  
Participants with HIV Stage –3 and 4 were excluded from the study. Only those adjudged as HIV 
Stage-1 (Asymptomatic HIV and Symptomatic -HIV (stage-2) were included for the study. Participants with 
malaria parasite infection as at the time of study were also excluded. Participants with tuberculosis were 
excluded and subjects with known fertility problems before contracting HIV infection were also excluded. Hence 
the female participants used were those with no prior fertility problems until the existence of HIV infection.  
 
2.2 methods 
Antibodies to HIV-1 and HIV-2 in Human Plasma were detected using Abbott Deterimine system, Immunoassay 
method [(Trinity Biotech UniGold Assay Kit (Trinity Biotech PLC, Ireland)] and imunochromatographic method 
[(HIV 1 and 2 STAT-PAK Assay kit (Chembio diagnostic system, INC New York, USA)] respectively as 
described by the manufacturers of the kits. Determination of Zinc and Copper by Atomic Absorption 
Spectroscopy (AAS): In the flame AAS, the principle is based on the dissociation of the element from its 
chemical bonds. This is then placed in an unexcited or ground state (neutral atom). Thus, the neutral atom is at a 
low energy level in which it is capable of absorbing radiation at a very narrow bandwidth corresponding to its 
own line spectrum. The amount of radiant energy absorbed at a characteristic wavelength in the flame is 
proportional to the concentration of the element present in the sample. Quantification is achieved by preparing 
standards of the element. For Zinc (Zn), the plasma was diluted 1:4 with water and aspirated to AAS. Standards 
and blanks were prepared by diluting with 5% glycerin (series of standards 1, 3 and 6 were recommended, 
however, 1 and 3 ppm were enough which have comparable concentration with sample). The instrument was set 
at zero with 5% glycerol in deionized water then the samples and standard were serially aspirated and analyzed 
at 213.8nm in AAS, unexcited zinc atom absorbs light of the same wavelength as that emitted by zinc in the 
excited state. The amount of light absorbed is proportional to the concentration of zinc present in solution.  The 
results displayed digitally part per million (ppm) and converted to µg/dl by multiplying each result by 100. For 
copper (Cu): The plasma was diluted 1:1 with water, aspirated and read in AAS. Standards and blanks were 
prepared with 10% glycerin (recommended standards are 5 ppm and 15 ppm Cu; however, the lowest standard 
alone could be used). Standards and blanks were prepared accordingly. 
Determination of TNF-α and Interleukin-4 and 6, were done using Enzyme Linked Immunosorbent 
Assay (ELISA) kits (Glory Science Laboratory USA): The TNF-α, Interleukin-4 or 6 antigens and biotinylated 
monoclonal antibody specific for the TNF-α, Interleukin-4 or 6 were simultaneously incubated, after washing; 
the enzyme (streptovidin-peroxidase) was added, which reacts with antigen bound monoclonal antibody, the 
substrate solution acts on the bound enzyme to induce colour reaction product. The colour product is directly 
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proportional to the concentration of TNF-α, Interleukin-4 or 6 present in the sample.  
 
2.3 Statistical analysis 
The version 16 of SPSS package was used in statistical analysis. The variables were expressed as mean (±SD). 
The student t-test and analysis of variance (ANOVA) and post-hoc (LSD) were used to assess significant mean 
differences. Graph Pad Prism version 5.03 was used for graph presentations. 
 
3. Results 
Zinc and Copper in Tests groups and Control group at Follicular and Luteal Phases of Menstrual cycle 
The mean (±SD) plasma zinc level (ppm) in stage1 HIV females was not significantly different between 
follicular (0.769±0.096) and luteal (0.787±0.062) phases of menstrual cycle (P>0.05). Similarly, the mean (±SD) 
plasma zinc level (ppm) in stage 2 HIV females was not significantly different between follicular (0.704±0.021) 
and luteal (0.728±0.040) phases of menstrual cycle (P>0.05). In stage2 HIV females on ART, no significant 
difference was also observed in the mean zinc level (ppm) between follicular (0.867±0.048) and luteal 
(0.845±0.072) phases of menstrual cycle (P>0.05). The mean (±SD) zinc level (ppm) in Control females was 
significantly higher at follicular (1.018±0.092) compared to luteal (1.014±0.090) phases of menstrual cycle 
(P<0.05).  
However, the mean plasma zinc level (ppm) in stage 1 HIV females (0.769±0.096, 0.787±0.062), stage 
2 HIV females (0.704±0.021, 0.728±0.040) and stage 2 HIV females on ART (0.867±0.048, 0.845±0.072) were 
significantly lower compared to Control females (1.018±0.092, 1.014±0.090) at both follicular and luteal phases 
of menstrual cycle (P<0.05 respectively). Furthermore, the mean (±SD) zinc level (ppm) in stage 2 HIV females 
on ART (0.867±0.048, 0.845±0.072) was significantly higher compared to stage1 HIV females (0.769±0.096, 
0.787±0.062) and stage 2 HIV females (0.704±0.021, 0.728±0.040) at both follicular and luteal phases of 
menstrual cycle (P<0.05 respectively).  
The mean (±SD) copper concentration (ppm) in stage 1 HIV females was not significantly different 
between follicular (0.892±0.129) and luteal (0.929±0.128) phases of menstrual cycle (P>0.05). The mean (±SD) 
copper concentration (ppm) in stage 2 HIV females was not significantly different between follicular 
(0.856±0.086) and luteal (0.870±0.121) phases of menstrual cycle (P>0.05). No significant difference was 
observed in the mean copper level (ppm) in stage 2 HIV females on ART between follicular (0.951±0.134) and 
luteal (0.980±0.117) phases of menstrual cycle (P>0.05). There was no significant difference in the mean copper 
level (ppm) in Control females between follicular (1.138±0.187) and luteal (1.145±0.215) phases of menstrual 
cycle (P>0.05 respectively).    
The mean (±SD) copper concentration (ppm) in stage 1 HIV females (0.892±0.129, 0.929±0.128), 
stage 2 HIV females (0.856±0.086, 0.870±0.121) and stage 2 HIV females on ART (0.951±0.134, 0.980±0.117) 
were significantly lower compared to Control females at (1.138±0.187, 1.145±0.215) phases of menstrual cycle 
(P>0.05). Similarly, The mean (±SD) copper concentration (ppm) in stage 2 HIV females on ART (0.951±0.134, 
0.980±0.117) was significantly higher compared to stage 1 HIV females (0.892±0.129, 0.929±0.128) and stage 2 
HIV females (0.856±0.086, 0.870±0.121) at follicular and luteal phases of menstrual cycle (P<0.05) (See  Fig 1). 
 
Cytokines (IL-6, IL-4 and TNFα) in Tests groups and Control group at Follicular and Luteal Phases of 
Menstrual cycle 
The mean (±SD) plasma IL-6 level (pg/ml) in stage 1HIV females was not significantly different between 
follicular (387.4±148.1) and luteal (347.4±172.6) phases of menstrual cycle (P>0.05). The mean (±SD) plasma 
IL-6 level (pg/ml) in stage 2 HIV females was significantly lower follicular phase (474.1±153.2) compared to 
luteal (583.3±271.3) phases of menstrual cycle (P<0.05). However, the mean plasma IL-6 level (pg/ml) in stage 
2 HIV females on ART was not significantly different between follicular (224.9±54.6) and luteal (296.6±143.7) 
phases of menstrual cycle (P>0.05). Similarly, the mean plasma IL-6 level (pg/ml) in Control females showed no 
significant difference between follicular (217.6±64.9) and luteal (204.6±36.7) phases of menstrual cycle 
(P>0.05).  
On the other hand,   The mean (±SD) plasma IL-6 level (pg/ml) in stage 1 HIV females (387.4±148.1, 
347.4±172.6) and stage 2 HIV females (474.1±153.2, 584.3±271.3) were significantly higher compared to 
Control females (217.6±64.9, 204.6±36.7) at both phases of menstrual cycle (P<0.05 respectively). Furthermore, 
the mean (±SD) plasma IL-6 level (pg/ml) in stage 2 HIV females on ART (224.9±54.6, 296.6±143.7) was 
significantly lower compared to stage 2 HIV females (474.1±153.2, 584.3±271.3) at both phases of menstrual 
cycle (P<0.05 respectively).  
The mean (±SD) plasma IL-4 level (pg/ml) in stage 1 HIV females was significantly lower at follicular 
phase (327.1±116.2) compared to luteal (440.9±126.9) phases of menstrual cycle (P<0.05). However, the mean 
(±SD) plasma IL-4 level (pg/ml) in stage 2 HIV females was not significantly different between follicular 
(627.2±231.3) and luteal (660.2±254.2) phases of menstrual cycle (P>0.05). However, the mean (±SD) plasma 
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IL-4 level (pg/ml) in stage 2 HIV females on ART was significantly lower at follicular phase (354.9±207.7) 
compared to luteal (497.6±216.1) phase of menstrual cycle were compared (P<0.05). The mean plasma IL-4 
value (pg/ml) in Control females was also significantly lower at follicular phase (210.7±71.2) compared to luteal 
phase (334.8±76.5) of menstrual cycle (P<0.05).  
Furthermore, the mean plasma IL-4 level (pg/ml) in stage 1 HIV females (327.1±116.2, 440.9±126.9), 
stage 2 HIV females (627.2±231.3, 660.4±254.2) and stage 2 HIV females on ART (354.9±207.7, 497.6±216.1) 
were significantly higher compared to Control females (210.70±71.2, 334.8±76.5) at follicular and luteal phases 
of menstrual cycle (P<0.05 in each case). Similarly, the mean plasma IL-4 level (pg/ml) was significantly lower 
in stage 2 HIV females on ART (354.9±207.7, 497.6±216.1) compared to stage 2 HIV females (627.2±231.3, 
660.2±254.2) at both  phases of menstrual cycle (P<0.05).  
The mean (±SD) plasma TNFα level (pg/ml) in stage 1 HIV females was significantly higher at 
follicular (843.1±359.2) compared to luteal (504.2±270.8) phases of menstrual cycle (P<0.05). The mean (±SD) 
plasma TNFα level (pg/ml) in stage 2 HIV females was significantly higher at follicular phase (949.6±335.7) 
compared to luteal (788.2±171.7) phase of menstrual cycle (P<0.05). However, the mean (±SD) plasma TNFα 
level (pg/ml) in stage 2  HIV females on ART showed no significant difference between follicular (483.6±160.0) 
and luteal (519.2±197.8) phases of menstrual cycle (P>0.05). However, the mean plasma TNFα value (pg/ml) in 
Control females was significantly lower at follicular phase (211.8±57.6) compared to luteal (333.0±72.2) phase 
of menstrual cycle (P<0.05).  
However, the mean (±SD) plasma TNFα level (pg/ml) in stage 1 HIV females (843.1±359.2, 
504.2±270.8), stage 2  HIV females (949.6±335.7, 788.2±171.7), stage 2 HIV females on ART (483.8±160.0, 
519.2±197.8) were significantly higher compared with the values in Control females (211.8±57.6, 333.0±72.2) 
(P<0.05 respectively). Furthermore, the mean (±SD) plasma TNFα level (pg/ml) in stage 2 HIV females on ART 
(483.8±160.0, 519.2±197.8) was significantly lower compared to stage 1 HIV females (843.1±359.2, 
504.2±270.8) and stage 2 HIV females (949.6±335.7, 788.2±171.7) at follicular and luteal phases of menstrual 
cycle (P<0.05) (See Fig 2) 
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4. Discussion 
The insignificant difference in the levels of zinc and copper in HIV infected females with or without ART 
between the follicular and luteal phases of menstrual cycle shows that there was minimal or no variation in 
immune response between the two phases of menstrual cycle. This is inconsistent with the observation in the 
Control subjects where there was significantly higher level of zinc at follicular phase compared to luteal phase. 
This has been documented previously in apparently healthy women (Das and Chowdhury, 1997). The 
insignificant variations noted in HIV infected females could be attributed to hormonal and metabolic changes 
during menstrual cycle. However, the significantly lower levels of Zn and Cu in HIV infected females compared 
to Control females at follicular and luteal phases of menstrual cycle is consistent with previous reports  (Akinola, 
2012). This implies immunosuppression since these two elements have been associated with effective immune 
function (Lukasewyez and Prohaska, 1990, Prasad, 2007). The role of Zn and Cu in the ovarian cycle cannot be 
overemphasized. For instance, copper is closely associated with estrogen receptors and function and deficiency 
states may manifest with menstrual irregularity (Bedwal and Bahuguna, 1994). Recent report by Clancy 
documented that reproductive function of women may be tied to their immune status and leftover energy is 
dedicated to reproduction. The implications of zinc and copper deficiencies in HIV infected women may include 
the impairment of immune status of the affected women considering the immunological roles of these elements 
(Prasad, 2000). Further implications of zinc deficiency include Hypogonadism, (a condition in which the ovaries 
do not produce enough sex hormones), amenorrhea and increased prevalence of menstrual and reproductive 
dysfunction considering the roles of zinc in menstruation (Bedwal and Bahuguna, 1994). Reduced zinc level may 
also be associated with rapid atrophy of the thymus, lymphopenia and increased cell death (apoptosis) (Elmes 
and Jones, 1980). These may worsen the progression of HIV disease in affected women. Zinc deficiency has 
been reported to be associated with reduction of primary and secondary antibody responses especially those 
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involved in T-cell development like heterologous red blood cell. This also reduces antibody responses and 
generation of splenic cytotoxic T-cells after immunization (Baum et al, 2000). Other implications of the 
significantly low levels of plasma zinc and copper in HIV infected females could be HIV disease progression as 
a result of increased opportunistic infections which is always common in affected individuals. This is 
substantiated by previous reports (Baum et al, 1997).  
The significantly higher levels of TNFα in HIV infected females not on ART at follicular phase 
compared to luteal phase of menstrual cycle implies significant inflammatory reaction at follicular phase of 
menstrual cycle which may be due to some hormonal changes in HIV infection. Increased level of pro-
inflammatory cytokines at the follicular phase when compared to the luteal phase in HIV infected female 
subjects has been previously reported (Al-Harthi et al., 2007). The significantly higher level of TNFα in HIV 
female subjects at the follicular phase when compared with the luteal phase is inconsistent with findings in 
healthy women. It has been documented that in apparently healthy women, TNFα is generally higher at the luteal 
phase during which the population of activated monocytes, which secret TNFα, are reported to be higher 
(Brannstrom, 1999). Reports of IL-6 levels during the menstrual cycle phases have been controversial. Whereas 
Angstwurm et al reported higher levels of IL-6 during the follicular phase of menstrual cycle, (Konecna et al, 
2000) reported higher levels during the luteal phase which is consistent with the present study.  
Further implication of zinc and copper deficiency in HIV infected women is exaggeration of dangerous 
inflammatory cytokines including tumor necrosis factor alpha (TNFα) (Klaus-Helge and Lothar, 2003). This 
may be related to the high incidence of neoplasms in HIV infected people. These reports are consistent with the 
present study. HIV is a chronic inflammatory disease and is said to induce a Th-1type immune response which is 
characterized by the production of harmful pro-inflammatory cytokines such as IL-6, IL-10, and TNFα 
(Chowdhury et al, 2010). The implications of elevated cytokines on endocrine and metabolic functions have 
been previously reported (Gatner, 2009) and this has far reaching effects on menstrual and reproductive 
functions of the affected women (O’ Brien, 2007). Zinc plays a role in inhibiting Tumor necrosis factor alpha 
(Flieger et al, 1989) which has been implicated in the pathophysiology of HIV/AIDS induced wasting and 
cachexia (Beutler B and Cerami, 1987). Deficiency states therefore, lead to over production of pro-inflammatory 
cytokines such as IL-6 and TNFα (Rosenberg and Fauci, 1989). Zinc deficiency also is associated with reduction 
in the production of anti-inflammatory cytokines particularly IL-4, a growth factor for T-cell helpers (Dowd et al. 
1986). IL-4 is said to inhibit the production of TNFα by monocytes (Hart et al, 1989). This highlights the 
potential role of adequate Zinc status in preventing HIV progression (Rosenberg and Fauci, 1990).  
The significantly higher levels of zinc and copper in HIV infected females on ART compared to their 
counterparts without treatment at both follicular and luteal phases of menstrual cycle imply that administration of 
antiretroviral therapy had some beneficial effects on these patients. This has been previously reported (Kassu et 
al, 2006). However, Silberry et al noted that administration of high or very low zinc concentrations may interfere 
with HIV replication. The author noted that selective blockade of active zinc finger site of HIV may inhibit the 
virus and spare the immune cells while progressive depletion of intracellular zinc may compromise the host cell 
thereby leading to apoptosis. Further reports indicate that excessive administration of zinc may contribute to HIV 
disease progression as a result of interference of copper and iron utilization which affects HDL cholesterol 
concentration and monocytes function (Schlesinger et al, 1993). The improved concentrations of zinc and copper 
in HIV infected women on ART has far reaching effects in reversing menstrual irregularities and restoring 
fertility or reproductive function . This highlights the beneficial effects of early diagnosis and treatment which 
probably improves the immunological response in the affected individuals with consequent reduction of 
opportunistic infections. 
 
5. Conclusion 
In conclusion, zinc and copper deficiencies occur in HIV infected women which may affect disease progression 
and worsen the prognosis. The introduction of ART seems to improve this condition.  
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